MX2010005629A - Preparacion farmaceutica para tratamiento de hiperplasia prostatica benigna. - Google Patents
Preparacion farmaceutica para tratamiento de hiperplasia prostatica benigna.Info
- Publication number
- MX2010005629A MX2010005629A MX2010005629A MX2010005629A MX2010005629A MX 2010005629 A MX2010005629 A MX 2010005629A MX 2010005629 A MX2010005629 A MX 2010005629A MX 2010005629 A MX2010005629 A MX 2010005629A MX 2010005629 A MX2010005629 A MX 2010005629A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical preparation
- benign prostatic
- prostatic hyperplasia
- treating benign
- protease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invención se refiere al uso de por lo menos una proteasa para la fabricación de un medicamento para el tratamiento y/o prevención de la hiperplasia/hipertrofia prostática benigna, en donde el medicamento se adapta para la administración enteral, por lo menos una proteasa se selecciona el grupo que consiste de proteasas de planta, animales no mamíferos y microbios y por lo menos una proteasa se administra en una cantidad de 1 a 100 mg/kg de peso corporal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0196207A AT506095A1 (de) | 2007-12-03 | 2007-12-03 | Verwendung von proteasen |
PCT/AT2008/000428 WO2009070818A1 (en) | 2007-12-03 | 2008-12-03 | Pharmaceutical preparation for treating benign prostatic hyperplasia |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010005629A true MX2010005629A (es) | 2010-08-18 |
Family
ID=40404976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010005629A MX2010005629A (es) | 2007-12-03 | 2008-12-03 | Preparacion farmaceutica para tratamiento de hiperplasia prostatica benigna. |
Country Status (11)
Country | Link |
---|---|
US (1) | US8231870B2 (es) |
EP (2) | EP2559439B1 (es) |
JP (1) | JP2011505385A (es) |
AT (1) | AT506095A1 (es) |
CA (1) | CA2705986C (es) |
DK (1) | DK2559439T3 (es) |
ES (1) | ES2528348T3 (es) |
MX (1) | MX2010005629A (es) |
PL (1) | PL2559439T3 (es) |
RU (1) | RU2485971C2 (es) |
WO (1) | WO2009070818A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI482629B (zh) * | 2008-07-01 | 2015-05-01 | Tobishi Pharmaceutical Co | 下泌尿道疾病治療劑及下泌尿道症狀改善劑 |
EP2341925B1 (en) * | 2008-09-10 | 2014-11-26 | PT. Dexa Medica | Thrombolytic/ anti thrombosis agent and its production method |
ES2694582T3 (es) * | 2011-01-31 | 2018-12-21 | Lucolas-M.D. Ltd. | Combinaciones de inhibidores de aromatasa y antioxidantes |
EP2707019B1 (en) | 2011-05-12 | 2016-06-29 | Smith & Nephew Orthopaedics AG | Wound debridement compositions containing seaprose and methods of wound treatment using same |
RU2014145270A (ru) * | 2012-05-11 | 2016-07-10 | Смит & Невью, Инк. | Способ и композиция для разрушения бактериальной биопленки |
ITMI20121997A1 (it) * | 2012-11-23 | 2014-05-24 | Velleja Res Srl | Composizioni fibrinolitiche per la prevenzione e il trattamento degli stati flebotrombotici |
US10086053B2 (en) | 2012-12-06 | 2018-10-02 | Giuseppe CARPIGNOLI | Therapeutic vegetable substances |
ITTO20121050A1 (it) | 2012-12-06 | 2014-06-07 | Giuseppe Carpignoli | Sostanze vegetali ad effetto curativo |
CA2926183C (en) * | 2013-10-23 | 2018-07-03 | Gemvax & Kael Co., Ltd. | Composition for treating and preventing benign prostatic hyperplasia |
HUP1400294A2 (hu) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Clopidogrel új alkalmazása |
JP6920199B2 (ja) * | 2014-08-25 | 2021-08-18 | アナタラ・ライフサイエンスズ・リミテッド | 抗微生物剤耐性を回避する抗下痢製剤 |
JP7127013B2 (ja) | 2016-07-27 | 2022-08-29 | スミス アンド ネフュー インコーポレイテッド | 表面から細菌バイオフィルムを低減または除去するためのサーモリシンの使用 |
IT201600081379A1 (it) | 2016-08-03 | 2018-02-03 | Neilos S R L | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. |
US11413300B2 (en) | 2017-01-30 | 2022-08-16 | Smith & Nephew, Inc. | Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces |
JP7207878B2 (ja) * | 2018-06-27 | 2023-01-18 | 小林製薬株式会社 | ナットウキナーゼを含む食品 |
JP7207877B2 (ja) * | 2018-06-27 | 2023-01-18 | 小林製薬株式会社 | ナットウキナーゼを含む食品 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0456724B1 (en) * | 1989-01-27 | 1995-05-03 | Immunolytics, Inc. | Composition and method for treating benign prostatic hypertrophy |
JPH05229983A (ja) * | 1992-02-21 | 1993-09-07 | Sankyo Co Ltd | レトロジヒドロカルコン化合物 |
DE4305460C2 (de) | 1993-02-23 | 1997-09-04 | Albert Dr Scheller | Pharmazeutische oder kosmetische, Enzyme enthaltende Zubereitung, Verfahren zu deren Herstellung und deren Verwendung |
JP3978250B2 (ja) * | 1996-08-16 | 2007-09-19 | 株式会社フジモト・コーポレーション | テストステロン5α−リダクターゼ阻害剤 |
US20010025059A1 (en) * | 2000-01-10 | 2001-09-27 | Kastke Floyd A. | Composition and method for treating non-bacterial prostatitis |
ZA200002342B (en) | 2000-05-12 | 2001-01-11 | Pharmachoice Healthcare Propri | Nutritional supplement. |
EP1443954B1 (en) | 2001-10-26 | 2010-11-24 | The Scripps Research Institute | Targeted thrombosis by tissue factor polypeptides |
US20060034824A1 (en) * | 2002-09-19 | 2006-02-16 | Santana Cristiano A R | Pharmaceutical composition comprising carriers for products |
LV13161B (en) * | 2004-02-16 | 2005-07-20 | Maris Skromanis | Proteolytic pharmaceutical composition |
US20060024385A1 (en) | 2004-07-27 | 2006-02-02 | Pedersen Mark A | Metabolic capacity enhancing compositions and methods for use in a mammal |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
RU2306145C1 (ru) * | 2006-03-28 | 2007-09-20 | Олег Викторович Бейдик | Средство для лечения хронического простатита |
-
2007
- 2007-12-03 AT AT0196207A patent/AT506095A1/de not_active Application Discontinuation
-
2008
- 2008-12-03 RU RU2010127336/15A patent/RU2485971C2/ru not_active IP Right Cessation
- 2008-12-03 PL PL12192951T patent/PL2559439T3/pl unknown
- 2008-12-03 CA CA2705986A patent/CA2705986C/en not_active Expired - Fee Related
- 2008-12-03 WO PCT/AT2008/000428 patent/WO2009070818A1/en active Application Filing
- 2008-12-03 US US12/745,776 patent/US8231870B2/en active Active
- 2008-12-03 JP JP2010536280A patent/JP2011505385A/ja active Pending
- 2008-12-03 ES ES12192951.7T patent/ES2528348T3/es active Active
- 2008-12-03 EP EP12192951.7A patent/EP2559439B1/en not_active Not-in-force
- 2008-12-03 EP EP08856631A patent/EP2224948A1/en not_active Withdrawn
- 2008-12-03 DK DK12192951.7T patent/DK2559439T3/en active
- 2008-12-03 MX MX2010005629A patent/MX2010005629A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP2559439A1 (en) | 2013-02-20 |
ES2528348T3 (es) | 2015-02-09 |
US8231870B2 (en) | 2012-07-31 |
EP2224948A1 (en) | 2010-09-08 |
US20100254968A1 (en) | 2010-10-07 |
RU2010127336A (ru) | 2012-01-10 |
JP2011505385A (ja) | 2011-02-24 |
RU2485971C2 (ru) | 2013-06-27 |
CA2705986C (en) | 2017-06-13 |
WO2009070818A1 (en) | 2009-06-11 |
PL2559439T3 (pl) | 2015-04-30 |
EP2559439B1 (en) | 2014-11-26 |
CA2705986A1 (en) | 2009-06-11 |
DK2559439T3 (en) | 2014-12-08 |
AT506095A1 (de) | 2009-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010005629A (es) | Preparacion farmaceutica para tratamiento de hiperplasia prostatica benigna. | |
TN2009000137A1 (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
WO2001085212A3 (en) | Drug delivery systems for photodynamic therapy | |
WO2005117954A3 (en) | Compositions and methods for treatment of neovascular diseases | |
ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
MX2010014233A (es) | Compuestos quimicos 251. | |
TW200615266A (en) | Organic compounds | |
EP2170876A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ISOXAZOLE DERIVATIVES FOR PREVENTING AND TREATING RESTENOSIS | |
TW200602328A (en) | Quinazoline derivatives | |
MX338338B (es) | Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias. | |
EA200800798A1 (ru) | Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха | |
UA92907C2 (uk) | Похідні тетрагідроіндазолону | |
MX2009004561A (es) | Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor. | |
UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
TW200637618A (en) | Compositions and methods for treating conditions of the nail unit | |
RU2007138867A (ru) | Режимы дозирования транс-кломифена | |
TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
GB0623258D0 (en) | Thiadiazole derivatives for the treatment of neuro-degenerative diseases | |
TW200635616A (en) | Organic compounds | |
NZ597060A (en) | Composition for the treatment of benign prostate hyperplasia comprisin degarelix | |
SG160323A1 (en) | Methods for controlling angiogenesis and cell proliferation | |
SE0950392L (sv) | Sammansättning för behandling av hudåkommor | |
WO2007130501A3 (en) | Combination therapy for treatment of cancer | |
EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |